Next Generation News and Research

RSS

CareCloud announces release of cloud-based EHR solution

CareCloud, the fastest-growing provider of cloud-based practice management, electronic health records, and medical billing software and services, today announced the next generation release of CareCloud Charts, the company's cloud-based EHR solution.

16 Jul 2013

Exalenz Bioscience launches BreathID Hp to test and treat H. pylori

Exalenz Bioscience, developer of advanced diagnostic systems that use a patient's breath to detect and help manage gastrointestinal and liver conditions, announced today the global launch of the BreathID Hp, a next generation device in the company's BreathID product line.

15 Jul 2013

Cambridge Epigenetix introduces TrueMethyl kits for epigenetics industry

Cambridge Epigenetix Ltd., a spin out biosciences company, has announced the launch of its TrueMethyl kits.

15 Jul 2013

Robert H. Lurie Comprehensive Cancer Center receive highest rating

The Robert H. Lurie Comprehensive Cancer Center of Northwestern University received its highest rating, an overall "outstanding," on the competitive renewal of its National Cancer Institute Cancer Center Support Grant, along with recommended funding of $24.9 million over the next five years.

15 Jul 2013

ASN Foundation for Kidney Research grants $3M for meritorious research in 2013

American Society of Nephrology (ASN) and the ASN Foundation for Kidney Research will fund $3 million in original, meritorious research in 2013.

15 Jul 2013

Global recruitment drive to bring best cancer experts to Manchester now underway

A global recruitment drive to bring 20 of the world's best cancer experts and their teams to Manchester, in the United Kingdom, is now underway.

From The University of Manchester 12 Jul 2013

PathoQuest closes new fundraising of EUR 3.8 million

PathoQuest, a new generation molecular diagnostics company that offers a new approach based on NGS (Next Generation Sequencing) in the field of infectious diseases, announces today the closing of a new fundraising of EUR 3.8 million.

12 Jul 2013

Stem-cell therapy for treatment of stroke has benefits as well as risk: Research

While stem-cell therapy offers great promise for the treatment of stroke, much research remains to be done to show its long-term effectiveness and to understand the potential for dangerous side effects.

12 Jul 2013

Hydrogel method form synthetic scaffolds to support formation of blood vessels in engineered tissues

Next-generation hydrogels can form synthetic scaffolds to support the formation of replacement tissues and organs in the emerging area of regenerative medicine. Embedding peptides into the hydrogels stimulates the growth of essential microvascular networks to ensure a good blood supply.

12 Jul 2013

TYRX's AIGISRx R Antibacterial Envelope technology gets FDA clearance

TYRX, Inc. announced today that it has received U.S. Food and Drug Administration clearance to market the Fully Resorbable AIGISRx R Antibacterial Envelope for use with pacemakers and implantable cardioverter defibrillators.

10 Jul 2013

Study shows disrupted micronuclei may prove to be a valuable tool for detecting cancer

Scientists studying cancer development have known about micronuclei for some time. These erratic, small extra nuclei, which contain fragments or whole chromosomes that were not incorporated into daughter cells after cell division, are associated with specific forms of cancer and are predictive of poorer prognosis.

10 Jul 2013

Atomo Diagnostics, BBI Solutions sign agreement for global rollout out of AtomoRapid test

Medical technology developer Atomo Diagnostics and market leading diagnostic company BBI Solutions have entered into an agreement to commercialise Atomo’s award winning, integrated rapid blood test platform, AtomoRapid.

9 Jul 2013

Disrupted micronuclei might play more active role in carcinogenesis, new study finds

9 Jul 2013

Penumbra announces launch of 5MAX ACE device for acute ischemic stroke treatment

Today, Penumbra, Inc. announced the launch and wide availability of the 5MAX ACE, a next generation clot extraction device that uses aspiration alone to engage and remove blood clots causing an acute ischemic stroke.

8 Jul 2013

Study describes how human mammary gland becomes highly sensitive to insulin during lactation

Why do so many mothers have difficulty making enough milk to breastfeed? A new study by scientists at Cincinnati Children's Hospital Medical Center and the University of California Davis adds to their previous research implicating insulin's role in lactation success.

6 Jul 2013

GAPVAC aims to develop personalized therapeutic vaccines for cancer

A highly innovative project supported by a €6 million European Union Framework 7 (EU FP7) program grant to develop a novel class of therapeutic cancer vaccines is now under way.

4 Jul 2013

UH and Case Western Reserve University to develop diagnostic tests to determine HIV drug resistance

Case Western Reserve University has signed an exclusive worldwide licensing agreement granting University Hospitals Case Medical Center rights to a series of diagnostic tests to determine drug resistance and co-receptor tropism in human immunodeficiency virus.

2 Jul 2013

Study reports new mechanism that regulates specification of lymphocytes

Scientists at an Academy of Finland Centre of Excellence have discovered a new mechanism regulating the immune response that can leave a person susceptible to autoimmune diseases.

28 Jun 2013

Children with congenital heart disease require higher levels of Vitamin D intake prior to surgery

Until now, there has been no research dedicated to the importance of Vitamin D supplementation in children with congenital heart disease (CHD). However, over the past few years, researchers at the Children's Hospital of Eastern Ontario (CHEO) Research Institute and Cardiovascular Surgery Program teamed with the Canadian Critical Care Trials Group to understand the impact of cardiac surgery on the Vitamin D status of infants and children, to be printed next month in Anesthesiology.

27 Jun 2013

Janssen, Johnson & Johnson Innovation establish IBD research alliance with Mount Sinai

Janssen Biotech, Inc. and Johnson & Johnson Innovation announced today the establishment of a research alliance with The Icahn School of Medicine at Mount Sinai to advance the scientific understanding of inflammatory bowel disease and the discovery of next generation therapeutic solutions.

27 Jun 2013

Next Generation News and Research

CareCloud announces release of cloud-based EHR solution

Exalenz Bioscience launches BreathID Hp to test and treat H. pylori

Cambridge Epigenetix introduces TrueMethyl kits for epigenetics industry

Robert H. Lurie Comprehensive Cancer Center receive highest rating

ASN Foundation for Kidney Research grants $3M for meritorious research in 2013

Global recruitment drive to bring best cancer experts to Manchester now underway

PathoQuest closes new fundraising of EUR 3.8 million

Stem-cell therapy for treatment of stroke has benefits as well as risk: Research

Hydrogel method form synthetic scaffolds to support formation of blood vessels in engineered tissues

TYRX's AIGISRx R Antibacterial Envelope technology gets FDA clearance

Study shows disrupted micronuclei may prove to be a valuable tool for detecting cancer

Atomo Diagnostics, BBI Solutions sign agreement for global rollout out of AtomoRapid test

Disrupted micronuclei might play more active role in carcinogenesis, new study finds

Penumbra announces launch of 5MAX ACE device for acute ischemic stroke treatment

Study describes how human mammary gland becomes highly sensitive to insulin during lactation

GAPVAC aims to develop personalized therapeutic vaccines for cancer

UH and Case Western Reserve University to develop diagnostic tests to determine HIV drug resistance

Study reports new mechanism that regulates specification of lymphocytes

Children with congenital heart disease require higher levels of Vitamin D intake prior to surgery

Janssen, Johnson & Johnson Innovation establish IBD research alliance with Mount Sinai

Advancing Intracellular Delivery with LumiPore®

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Latest News